Longitudinal change in systolic (A) and diastolic (B) blood pressure (mmHg) in patients receiving atomoxetine at a target dose of 1.2 mg/kg/day (Arm 3) and summary of mean change in vital signs from baseline to endpoint in all treatment arms.